Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fallopian tube carcinoma.

G L Eddy, L J Copeland, D M Gershenson

    Obstetrics and Gynecology
    |October 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    MEK inhibitor resistance mechanisms and recent developments in combination trials.

    Cancer treatment reviews·2020
    Same author

    Low-grade serous carcinoma of the ovary or peritoneum.

    Annals of oncology : official journal of the European Society for Medical Oncology·2016
    Same author

    Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases.

    Gynecologic oncology·2015
    Same author

    Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010).

    European journal of cancer (Oxford, England : 1990)·2014
    Same author

    Tamoxifen is safe and effective in gynecological cancer patients with renal dysfunction.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2007
    Same author

    The clinical effectiveness of fluorescence and reflectance spectroscopy for the in vivo diagnosis of cervical neoplasia: an analysis by phase of trial design.

    Gynecologic oncology·2007
    Same journal

    The Political Determinants of Obstetric Prescribing.

    Obstetrics and gynecology·2026
    Same journal

    Glucagon-Like Peptide-1 Receptor Agonists and Risk of Adverse Maternal Pregnancy Outcomes: A Systematic Review and Meta-analysis.

    Obstetrics and gynecology·2026
    Same journal

    Milestones in Motion: Vaginal Birth After Cesarean.

    Obstetrics and gynecology·2026
    Same journal

    Ebola Virus in Pregnancy.

    Obstetrics and gynecology·2026
    Same journal

    A Quality-Improvement Study Evaluating Three Postpartum Prophylactic Oxytocin Rates and Blood Loss After Vaginal Birth.

    Obstetrics and gynecology·2026
    Same journal

    The Effects of Climate Change on Obstetric and Gynecologic Health.

    Obstetrics and gynecology·2026
    See all related articles

    This study reviewed 71 fallopian tube adenocarcinoma cases. Treatment outcomes showed no significant survival differences between surgery, radiation, and chemotherapy combinations for this rare cancer.

    Area of Science:

    • Gynecology
    • Oncology
    • Pathology

    Background:

    • Primary adenocarcinoma of the fallopian tube is a rare gynecologic malignancy.
    • It often presents with non-specific symptoms, leading to diagnostic challenges.

    Purpose of the Study:

    • To review treatment modalities and outcomes for primary fallopian tube adenocarcinoma.
    • To identify common presenting symptoms and physical findings.

    Main Methods:

    • Retrospective review of 71 cases treated at a major cancer center.
    • Analysis of presenting symptoms, physical findings, preoperative diagnoses, treatment regimens, and survival data.

    Main Results:

    • Common symptoms included abdominal pain, abnormal uterine bleeding, and vaginal discharge.

    Related Experiment Videos

  • A palpable abdominal or pelvic mass was the most frequent physical finding.
  • Median survival was 23 months, with no statistically significant differences among various treatment combinations (surgery alone, surgery plus radiation, surgery plus chemotherapy, or multimodal therapy).
  • Conclusions:

    • Primary fallopian tube adenocarcinoma requires a high index of suspicion due to non-specific symptoms.
    • Current treatment strategies, including various combinations of surgery, radiation, and chemotherapy, yield similar survival outcomes.